{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:51:25Z","timestamp":1773370285217,"version":"3.50.1"},"reference-count":15,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 1","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introduction. Stroke in young individuals is becoming increasingly prevalent worldwide. Its causes can vary widely, so a thorough investigation by a multidisciplinary team is needed. Pinpointing the precise underlying pathology responsible for the stroke yields benefits for patients, particularly in recurrent events.Case presentation. A 38-year-old man presented to the emergency department with symptoms suggestive of stroke, including right hemiparesis, dysarthria, ataxic gait, and right central facial palsy. The brain magnetic resonance image revealed an ischemic lesion located in the left basal ganglia and near the corona radiata. Following an extensive workup, a diagnosis of nephrotic was reached. Histopathology and the exclusion of secondary causes confirmed primary membranous nephropathy as the underlying condition.The patient underwent treatment tailored to address the specific glomerulopathy, along with anticoagulation therapy and immunosuppression as per current guidelines. Subsequent assessments showed stabilization of renal function, resolution of the edema, and the absence of new thromboembolic events during follow-up.Conclusion. The nephrotic syndrome should be recognized as a potential underlying cause of stroke in young patients and, therefore, it should be included in the differential diagnosis during the evaluation of patients with coagulopathies. Nephrotic syndrome screening may be done by conducting a simple urinalysis readily available in most healthcare facilities.This underlines the importance of considering renal pathology in the assessment of stroke etiologies, especially when coagulation abnormalities are present.<\/jats:p>","DOI":"10.7705\/biomedica.7117","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:40:41Z","timestamp":1722354041000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Stroke associated with primary membranous nephropathy in a young adult: Case report","Evento cerebral isqu\u00e9mico asociado con nefropat\u00eda membranosa primaria en un adulto joven: reporte de caso"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0706-0060","authenticated-orcid":false,"given":"Juan Pablo","family":"Morales","sequence":"first","affiliation":[{"name":"Departamento de Medicina Interna, Universidad del Valle, Cali, Colombia;\u00a0Hospital Universitario del Valle Evaristo Garc\u00eda, Cali, Colombia"},{"name":"Departamento de Medicina Interna, Universidad del Valle, Cali, Colombia;\u00a0Hospital Universitario del Valle Evaristo Garc\u00eda, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"135286","doi-asserted-by":"crossref","unstructured":"Ekker MS, Boot EM, Singhal AB, Tan KS, Debette S, Tuladhar AM, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17:790-801. https:\/\/doi.org\/10.1016\/S1474-4422(18)30233-3","DOI":"10.1016\/S1474-4422(18)30233-3"},{"key":"135287","doi-asserted-by":"crossref","unstructured":"Boot E, Ekker MS, Putaala J, Kittner S, De Leeuw F-E, Tuladhar AM. Ischaemic stroke in young adults: A global perspective. J Neurol Neurosurg Psychiatry. 2020;91:411-7. https:\/\/doi.org\/10.1136\/jnnp-2019-322424","DOI":"10.1136\/jnnp-2019-322424"},{"key":"135288","doi-asserted-by":"crossref","unstructured":"Stack CA, Cole JW. A diagnostic approach to stroke in young adults. Curr Treat Options Cardiovasc Med. 2017;19:1-19. https:\/\/doi.org\/10.1007\/s11936-017-0587-6","DOI":"10.1007\/s11936-017-0587-6"},{"key":"135289","doi-asserted-by":"crossref","unstructured":"Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. https:\/\/doi.org\/10.1161\/01.STR.24.1.35","DOI":"10.1161\/01.STR.24.1.35"},{"key":"135290","doi-asserted-by":"crossref","unstructured":"Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome \u2013associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;73:513-20. https:\/\/doi.org\/10.2215\/CJN.10131011","DOI":"10.2215\/CJN.10131011"},{"key":"135291","doi-asserted-by":"crossref","unstructured":"Zou H, Li Y, Xu G. Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy. BMC Nephrol. 2019;20:1-11. https:\/\/doi.org\/10.1186\/s12882-019-1637-y","DOI":"10.1186\/s12882-019-1637-y"},{"key":"135292","doi-asserted-by":"crossref","unstructured":"Francis JM, Beck Jr LH, Salant DJ. Membranous nephropathy: A journey from bench to bedside. Am J Kidney Dis. 2016;68:138-47. https:\/\/doi.org\/10.1053\/j.ajkd.2016.01.030","DOI":"10.1053\/j.ajkd.2016.01.030"},{"key":"135293","doi-asserted-by":"crossref","unstructured":"Alsharhan L, Beck Jr LH. Membranous nephropathy: Core Curriculum 2021. Am J Kidney Dis. 2021. https:\/\/doi.org\/10.1053\/j.ajkd.2020.10.009","DOI":"10.1053\/j.ajkd.2020.10.009"},{"key":"135294","doi-asserted-by":"crossref","unstructured":"Beck Jr LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21. https:\/\/doi.org\/10.1056\/NEJMoa0810457","DOI":"10.1056\/NEJMoa0810457"},{"key":"135295","doi-asserted-by":"crossref","unstructured":"Fahal IH, McClelland P, Hay C, Bell G. Arterial thrombosis in the nephrotic syndrome. Postgrad Med J. 1994;70:905-9. https:\/\/doi.org\/10.1136\/pgmj.70.830.905","DOI":"10.1136\/pgmj.70.830.905"},{"key":"135296","doi-asserted-by":"crossref","unstructured":"Lee T, Derebail VK, Kshirsagar AV, Chung Y, Fine JP, Mahoney S, et al. Patients with primary membranous nephropathy are at high risk of cardiovascular events. Kidney Int. 2016;89:1111-8. https:\/\/doi.org\/10.1016\/j.kint.2015.12.041","DOI":"10.1016\/j.kint.2015.12.041"},{"key":"135297","doi-asserted-by":"crossref","unstructured":"Roy C, Deschaintre Y, Sabbagh R, Roy D, Cardinal H, Boll\u00e9e G. Ischemic stroke of possible embolic etiology associated with nephrotic syndrome. Kidney Int Rep. 2017;2:988-94. https:\/\/doi.org\/10.1016\/j.ekir.2017.04.004","DOI":"10.1016\/j.ekir.2017.04.004"},{"key":"135298","doi-asserted-by":"crossref","unstructured":"Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol. 1998;9:444-50. https:\/\/doi.org\/10.1681\/ASN.V93444","DOI":"10.1681\/ASN.V93444"},{"key":"135299","doi-asserted-by":"crossref","unstructured":"Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019;381:36-46. https:\/\/doi.org\/10.1056\/NEJMoa1814427","DOI":"10.1056\/NEJMoa1814427"},{"key":"135300","doi-asserted-by":"crossref","unstructured":"Luzardo L, Ottati G, Cabrera J, Trujillo H, Garau M, Bedat CG, et al. Substitution of oral for intravenous cyclophosphamide in membranous nephropathy. Kidney360. 2020;1:943-9. https:\/\/doi.org\/10.34067\/KID.0002802020","DOI":"10.34067\/KID.0002802020"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7117\/5528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7117\/5613","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7117\/5528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:11:19Z","timestamp":1773324679000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":15,"journal-issue":{"issue":"Sp. 1","published-online":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7117","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"2024-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Presentaci\u00f3n de caso","name":"content_type","label":"Content Type"}]}}